IceCure Medical (ICCM) Operating Leases (2020 - 2026)

IceCure Medical (ICCM) has 7 years of Operating Leases data on file, last reported at $5000.0 in Q1 2026.

• Quarterly Operating Leases changed N/A year-over-year to $5000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5000.0 (changed N/A YoY) and the FY2025 annual result came in at $13000.0, down 97.17% from the prior year.
• Operating Leases retreated to $5000.0 in Q1 2026 per ICCM's latest filing, from $13000.0 in the prior quarter.
• Across five years, Operating Leases topped out at $459000.0 in Q4 2024 and bottomed at $5000.0 in Q1 2026.
• The 5-year median for Operating Leases is $376000.0 (2023), against an average of $256600.0.
• The widest annual swing landed in 2024, when Operating Leases grew 22.07%; it then slumped 97.17% in 2025.
• Tracing ICCM's Operating Leases over 5 years: stood at $430000.0 in 2022, then declined by 12.56% to $376000.0 in 2023, then gained by 22.07% to $459000.0 in 2024, then tumbled by 97.17% to $13000.0 in 2025, then tumbled by 61.54% to $5000.0 in 2026.
• Per Business Quant, the three latest ICCM Operating Leases figures stand at $5000.0 (Q1 2026), $13000.0 (Q4 2025), and $459000.0 (Q4 2024).

Peer Comparison